Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Breckenridge Announces Final Approval of its ANDA for Roflumilast Tablets

americanpharmaceuticalreviewOctober 12, 2018

Tag: Breckenridge Announces , ANDA , Roflumilast tablets

PharmaSources Customer Service